Can a diabetes pill help heart failure patients get rid of excess fluid?
NCT ID NCT05305495
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding empagliflozin (a diabetes drug) to standard diuretics helps hospitalized heart failure patients with moderate to advanced kidney disease urinate more fluid. 25 participants were given the combination, and researchers measured urine output. The goal was to see if this approach could overcome diuretic resistance and improve fluid removal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Institute of the McGill University Health Center
Montreal, Quebec, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a second diuretic boost recovery from heart failure?
- Can a new graft keep dialysis access working longer?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes